Uterine sarcoma: A retrospective study
β Scribed by Dr. B-Chen Wen; Ferial A. Tewfik; Hamed H. Tewfik; Jeffrey P. Long; Barrie Anderson
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 474 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
From 1965 to 1982, 86 analyzable patients with uterine sarcoma were treated. Nineteen patients (22 %) presented with advanced disease. For the patients with curable diseases (67 patients), the disease-free survivals with a median follow-up of 4.5 years are 40% (surgery only), 53% (surgery + chemotherapy), 46% (surgery + radiation & chemotherapy). The local failure rates are 43 % : 32 % :33 % , respectively. There is no statistical significance. The most important prognostic factor is the clinical extent of the tumor. The role of radiation therapy and chemotherapy will be discussed.
π SIMILAR VOLUMES
## Background: Uterine sarcomas are rare, charaterized by rapid clinical progression and poor prognosis, and their management has been a challenge. the purpose of this study was to investigate the clinical and histologic findings, treatment, and outcome of patients with uterine sarcoma in the south
Of 147 patients with reticulum cell sarcoma (RCS) from one institution, 33 (22.4%) required a laparotomy at the onset of their disease. T h e presenting signs and symptoms, surgical procedures, operative findings, treatment, and survival of these patients have been reviewed. The gastrointestinal tra